These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14854798)

  • 1. A comparison between the effect of intravenously and orally administrated dicumarol on the plasma prothrombin levels in man.
    BJERKELUND CJ
    Scand J Clin Lab Invest; 1951; 3(2):115-20. PubMed ID: 14854798
    [No Abstract]   [Full Text] [Related]  

  • 2. EFFECTS of dicumarol on prothrombin levels.
    Hosp Manage; 1950 Sep; 70(3):100. PubMed ID: 14773979
    [No Abstract]   [Full Text] [Related]  

  • 3. Fate of dicumarol in man; relationship between prothrombin time and plasma levels of dicumarol.
    WEINER M; SHAPIRO S
    Bull N Y Acad Med; 1949 Jul; 25(7):449. PubMed ID: 18152257
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of phenylindanedione on plasma prothrombin and factor V levels and a comparison with the effect of dicumarol.
    BJERKELUND CJ
    Scand J Clin Lab Invest; 1950; 2(2):83-91. PubMed ID: 15424627
    [No Abstract]   [Full Text] [Related]  

  • 5. Prothrombin conversion factor of dicumarol plasma.
    OWEN CA; BOLLMAN JL
    Proc Soc Exp Biol Med; 1948 Feb; 67(2):231-4. PubMed ID: 18907641
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of dicumarol-induced hypoprothrombinemia in man with emulsified vitamin K1 administered intravenously.
    WATKIN DM; VAN ITALLIE TB; LOGAN WB; GEYER RP; DAVIDSON CS; STARE FJ
    J Lab Clin Med; 1951 Feb; 37(2):269-71. PubMed ID: 14814353
    [No Abstract]   [Full Text] [Related]  

  • 8. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
    LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS
    Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship of plasma prothrombin concentration and the degradation rate of serum "prothrombin-converting factor" during dicumarol therapy.
    JACOX RF; BAYS RF
    Blood; 1950 Apr; 5(4):313-19. PubMed ID: 15411419
    [No Abstract]   [Full Text] [Related]  

  • 10. Variations in prothrombin and antithrombin following the administration of dicumarol.
    HURN M; BARKER NW; MANN FD
    Am J Clin Pathol; 1947 Sep; 17(9):712-8. PubMed ID: 20265749
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of tromexan and dicumarol on clotting time and prothrombin index].
    KRISTENSON A
    Nord Med; 1951 Jul; 46(29):1102-4. PubMed ID: 14863696
    [No Abstract]   [Full Text] [Related]  

  • 12. The complex mechanisms of the quick prothrombin test and the effect of dicumarol.
    MANN FD; HURN MM
    Am J Clin Pathol; 1950 Mar; 20(3):225-32. PubMed ID: 15432302
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimentally induced changes in the prothrombin level of the blood; quantitative studies in dogs given dicumarol; the effect of methylxanthines on prothrombin per se and when administered with dicumarol.
    QUICK AJ
    J Biol Chem; 1945; 161():33-44. PubMed ID: 21005712
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of dicumarol-induced hypoprothrombinemia in dogs with emulsified vitamin K1 administered intravenously.
    SHOSHKES M; GEYER RP; YEE GS; STARE FJ
    J Lab Clin Med; 1950 Oct; 36(4):531-6. PubMed ID: 14779068
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of two methods for determining prothrombin during dicumarol therapy.
    BEGTRUP H
    Acta Med Scand; 1954; 150(1):11-6. PubMed ID: 13196956
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme studies on human blood. VII. Prothrombin as determined with the isolation technic, in patients receiving dicumarol.
    SHINOWARA GY; SMITH WB
    Am J Clin Pathol; 1950 Apr; 20(4):341-8. PubMed ID: 15432322
    [No Abstract]   [Full Text] [Related]  

  • 18. [Variations in permeability, independent of variations in prothrombin time, produced by dicumarol].
    KUSCHINSKY G; LUDEWIG H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1950; 210(4-5):404-8. PubMed ID: 14777500
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulant effect of dicumarol at various prothrombin levels in dogs.
    MOSS NH; SCHAFER RL; KIRBY CK
    Proc Soc Exp Biol Med; 1948 Oct; 69(1):143-5. PubMed ID: 18889810
    [No Abstract]   [Full Text] [Related]  

  • 20. An altered prothrombin produced by dicumarol-treated rabbits.
    LEIN J; LEIN PS
    Am J Physiol; 1948 Dec; 155(3):394-401. PubMed ID: 18113179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.